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Background. Previous studies have shown that intratumoral hemorrhage is a common finding in glioblastoma multi-
forme, but is rarely observed in primary central nervous system lymphoma. Our aim was to reevaluate whether intra-
tumoral hemorrhage observed on T2-weighted imaging (T2WI) as gross intratumoral hemorrhage and on susceptibility-
weighted imaging as intratumoral susceptibility signal can differentiate primary central nervous system lymphoma 
from glioblastoma multiforme.
Patients and methods. A retrospective cohort of brain tumors from August 2008 to March 2013 was searched, and 
58 patients (19 with primary central nervous system lymphoma, 39 with glioblastoma multiforme) satisfied the inclu-
sion criteria. Absence of gross intratumoral hemorrhage was examined on T2WI, and an intratumoral susceptibility 
signal was graded using a 3-point scale on susceptibility-weighted imaging. Results were compared between primary 
central nervous system lymphoma and glioblastoma multiforme, and values of P < 0.05 were considered significant.
Results. Gross intratumoral hemorrhage on T2WI was absent in 15 patients (79%) with primary central nervous system 
lymphoma and 23 patients (59%) with glioblastoma multiforme. Absence of gross intratumoral hemorrhage could not 
differentiate between the two disorders (P = 0.20). However, intratumoral susceptibility signal grade 1 or 2 was diag-
nostic of primary central nervous system lymphoma with 78.9% sensitivity and 66.7% specificity (P < 0.001), irrespective 
of gross intratumoral hemorrhage.
Conclusions. Low intratumoral susceptibility signal grades can differentiate primary central nervous system lym-
phoma from glioblastoma multiforme. However, specificity in this study was relatively low, and primary central nervous 
system lymphoma cannot be excluded based solely on the presence of an intratumoral susceptibility signal.
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Introduction
Primary central nervous system lymphoma 
(PCNSL) represents approximately 2‒6% of all 
brain tumors and 1‒2% of all non-Hodgkin lym-
phomas.1,2 The vast majority of PCNSLs are diffuse 
large B-cell lymphomas, regardless of the patient’s 
immunological state, and primary T-cell lympho-
mas are uncommon in the central nervous system 
(CNS).3 The incidence of this pathology has recent-
ly been on the rise among both immunocompetent 
and immunocompromised populations.4
Histology is required for a definitive diagnosis, 
but radical surgical excision of PCNSL is not war-
ranted; even partial tumor resection seems to be 
a negative prognostic factor.2 Glioblastoma mul-
tiforme (GBM), on the other hand, requires maxi-
mal excision. Because symptomatic patients with 
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PCNSL often present with lesions of considerable 
size, steroid administration is sometime clinically 
indicated before pathological confirmation, result-
ing in low diagnostic yields for histological exami-
nation.5 Accurate diagnosis of PCNSL by initial im-
aging is thus crucial to avoid steroid treatment and 
facilitate biopsy, rather than resection that does not 
improve prognosis.
PCNSL has many documented imaging fea-
tures1,6-10, but may mimic other diseases or show 
atypical findings, making preoperative diagnosis 
of PCNSL imperfect even with current advanced 
imaging techniques.11,12 As another imaging meth-
od, susceptibility-weighted imaging (SWI) has re-
cently been reported to differentiate PCNSL from 
GBM, as the most common malignant primary 
brain tumor, nearly perfectly when intratumoral 
susceptibility signal (ITSS) that reflects hemor-
rhage is used.13-15
However, some reports have described PCNSL 
with cerebral hemorrhage even in non-HIV pa-
tients16-18 and hemorrhage may not be particular-
ly rare even among immunocompetent patients. 
Moreover, the relationship between ITSS and in-
tratumoral hemorrhage observed on conventional 
imaging modalities such as computed tomography 
(CT) or T2-weighted imaging (T2WI) in PCNSL 
cases has not been clarified in detail.13-15
Given these considerations, we have retrospec-
tively reviewed all patients with PCNSL and GBM 
encountered within a fixed period in our hospital 
to investigate the differential capabilities of gross 
intratumoral hemorrhage (GITH) on T2WI and 
ITSS grading on SWI.
Patients and methods
Patients
A retrospective cohort of brain tumors in the pathol-
ogy archives of our institution from August 2008 to 
March 2013 was searched for cases of PCNSL and 
GBM. From the database, we included all patients 
with pathologically diagnosed PCNSL and GBM 
who had preoperative CT and MRI studies includ-
ing T2WI and SWI. From the database, we found 
65 patients with pathologically diagnosed PCNSL 
and GBM who had undergone preoperative CT and 
MRI studies, including T2WI and SWI. Exclusion 
criteria were a history of organ transplantation (n 
= 1) or surgical intervention (i.e. biopsy or drain-
age) before initial MRI (n = 6). In total, 58 patients 
satisfied these criteria: 19 patients with PCNSL (10 
men, 9 women; mean age, 65.1 years; range, 26‒83 
years) and 39 patients with GBM (24 men, 15 wom-
en; mean age, 59.7 years; age range, 16‒87 years). 
Among PCNSL patients, all were diagnosed with 
B-cell lymphoma (diffuse large B-cell lymphoma, 
n = 17; precursor B cell lymphoma, n = 1), except 
1 case of T-cell lymphoma. No patient had history 
of acquired immunodeficiency syndrome or other 
immunodeficiency disorders. One patient with 
B-cell lymphoma had Sjögren syndrome and was 
treated with disease-modifying anti-rheumatic 
drugs. Another patient was treated for multiple 
sclerosis with steroid pulse therapy for 1 month 
prior to admission to our hospital. One patient 
with T-cell lymphoma showed positive results for 
human T-lymphotropic virus type 1 infection post-
operatively, but the lesion was limited to the CNS. 
Five patients with PCNSL had received steroids 
prior to MRI to diminish edema. This study was 
approved by the institutional review board. Given 
the retrospective design, the requirement for in-
formed consent was waived.
Image acquisition
Patients were imaged using a 3T MRI system 
(Magnetom Trio Tim or Skyra; Siemens Healthcare, 
Erlangen, Germany) with a 32-channel head coil. 
T2WI was acquired using a fast spin-echo sequence 
under the following conditions: repetition time 
(TR), 3200 ms; echo time (TE), 79 ms; matrix, 420 × 
448; field of view, 206×220 mm; matrix size, 0.49 × 
0.49 mm; 35 slices of 3 mm thickness with a 1 mm 
gap. SWI was acquired with a three-dimensional 
fully flow-compensated gradient echo sequence 
using the following parameters: TR, 28 ms; TE, 20 
ms; flip angle, 15°; matrix, 320 × 230; field of view, 
230 × 179 mm; matrix size, 0.72 × 0.78 mm. Slab size 
was 76.8 mm or 128 mm, partitioned into 64 slices 
of 1.2 or 2 mm (n = 28 and 30, respectively). SWI se-
quences were acquired before contrast administra-
tion. Diffusion-weighted imaging (DWI), pre- and 
post-contrast enhanced T1-weighted images were 
also routinely acquired. DWI was performed using 
a single-shot spin-echo (SE) echo planar sequence 
with following parameters: TR 5000ms, TE 84 ms, 
flip angle 90°, matrix 160 × 160, field of view 220 
× 220 mm, matrix size, 0.49 × 0.49 mm; 35 slices 
of 3 mm thickness with a 1 mm gap. Diffusion-
sensitizing gradients were applied in 3 directions 
with b factors of 0 and 1000 s/mm2. Apparent dif-
fusion coefficients (ADCs) were automatically cal-
culated by the operating console of the MR scanner 
and displayed as corresponding ADC maps. All 
patients underwent unenhanced CT with an in-
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plane resolution of 0.41 × 0.41 mm and slice thick-
nesses of 4‒8 mm in conventional scans and 5 mm 
in helical acquisitions using 16- or 64-detector-row 
FIGURE 1. Gross intratumoral hemorrhage (arrows) in primary central nervous system 
lymphoma (A) and glioblastoma multiforme (B) on T2-weighted image. Both cases 
show low-intensity areas representing intratumoral hemorrhage.
FIGURE 2. Intratumoral susceptibility signals in patients with primary central nervous system lymphoma: (A) Grade 1: multifocal 
tumors in bilateral temporal lobes show no intratumoral susceptibility signal on susceptibility-weighted imaging (SWI). (B) Grade 2: 
tumor in the left basal ganglia shows punctate low-intensity signals (arrows) on SWI. (C) Grade 3: tumor in the left thalamus shows 
multiple linear or nodular low-intensity signals (circle) on SWI. (D-F) Contrast-enhanced T1-weighted imaging shows primary central 
nervous system lymphomas with intense enhancement.
CT scanners (Aquilion 16 or Aquilion 64; Toshiba 
Medical Systems, Ohtawara, Japan).
Image analysis
Qualitative analysis including T2WI and contrast-
enhanced T1-weighted images (CE-T1WI) as well 
as SWI was conducted on a clinical picture archiv-
ing and communication system (Centricity, PACS 
workstation version 3.2; GE Medical Systems, 
Milwaukee, WI) by two board-certified neuroradi-
ologists (A.S. and T.D.; both with 5 years of expe-
rience in diagnostic radiology) who were blinded 
to the final diagnosis. First, they evaluated the ab-
sence of GITH. GITH was defined as nodular or lin-
ear hypo-intense foci observed on T2WI (Figure 1). 
Second, ITSS grading on SWI was conducted inde-
pendently by the same two neuroradiologists at 1 
month after GITH evaluation. As described by Kim 
et al.12, ITSS was defined as a dot-like or fine lin-
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was considered significant. All statistical analy-
ses were conducted using MedCalc for Windows 
(version 12.5.0.0; MedCalc Software, Mariakerke, 
Belgium).
Results
No significant differences in age (P = 0.39) or sex (P 
= 0.72) were found between patient groups. Inter-
observer agreement between the two evaluators 
was substantial for GITH (κ = 0.75, 95% confidence 
interval (CI) = 0.58‒0.92) and almost perfect for 
ITSS (κ = 0.88, 95% CI = 0.81‒0.96). ICC of ADCmin 
was 0.693 (95% CI = 0.48‒0.82).
CT showed no calcification in any cases. GITH 
was not observed in 15 patients (79%) with PCNSL 
and in 23 patients (59%) with GBM (Table 1), and 
ROC analysis thus failed to reveal any significant 
difference (P = 0.20). ITSS grades 1, 2 and 3 were 
found in 9, 6 and 4 PCNSL patients, respective-
ly, and in 4, 9 and 26 GBM patients, respectively 
(Table 2). GITHs were associated with grade 3 ITSS 
in almost all cases, except for 1 patient with GBM 
and 1 patient with PCNSL; both of these patients 
showed grade 2 ITSS. ITSS was not observed (i.e., 
grade 1) in 9 PCNSL patients (47.4%) and 4 GBM 
TABLE 1. Gross intratumoral hemorrhage (GITH) frequency in primary central nervous 
system lymphoma (PCNSL) and glioblastoma multiforme (GBM)
Pathological Diagnosis
GITH
Negative (%) Positive (%)
PCNSL 15 (79) 4 (21)
GBM 23 (59) 16 (41)
TABLE 2. Intratumoral susceptibility signal (ITSS) grading of primary central nervous 
system lymphoma (PCNSL) and glioblastoma multiforme (GBM)
Pathological Diagnosis
ITSS grading
Grade 1 (%) Grade 2 (%) Grade 3 (%)
PCNSL 9 (47) 6 (32) 4 (21)
GBM 4 (10) 9 (23) 26 (67)
TABLE 3. Enhancement patterns of primary central nervous system lymphoma 





Necrotic 3 37 
3-point scale: grade 1, no ITSS (Figure 2A); grade 
2, 1‒10 ITSSs (Figure 2B); and grade 3, ≥ 11 ITSSs 
(Figure 2C) within a tumor. Corresponding con-
trast-enhanced T1-weighted images are presented 
as tumor references (Figure 2D-F). Enhancement 
patterns on contrast-enhanced T1-weighted image 
were evaluated as necrotic or non-necrotic: necrotic 
was defined as solid enhancement with any loss of 
contrast enhancement.19 When absence of GITH, 
ITSS grading or enhancement patterns were dis-
cordant between evaluators, the final results were 
reached by consensus. To exclude low signal inten-
sity caused by calcification (defined as a CT attenu-
ation value >100 Hounsfield units), unenhanced 
CT was also referred to.
The same neuroradiologists (A.S. and T.D.) eval-
uated ADC maps using software (Image J version 
1.49a; NIH, Bethesda). Firstly, we selected all slices 
that included tumor. One round- or oval-shaped 
region of interest (area, approximately 0.3 cm2) was 
carefully placed on each slice of the ADC map of 
the whole tumor to include the area with the low-
est ADC value determined by visual inspection. 
Cystic, necrotic or hemorrhagic areas were care-
fully avoided by referencing to conventional MR 
images. Finally, the value of a region of interest 
with the lowest average ADC value was selected 
as a minimum ADC (ADCmin) value of the tumor 
in each case.20
Statistical analysis
Patient groups of PCNSL and GBM were com-
pared for age, sex and parameters using a t-test 
and a Pearson’s χ2 test, respectively. Inter-observer 
variability of GITH and ITSS grading was evalu-
ated using κ statistics. Inter-observer variability 
of the readers for ADC analysis was evaluated by 
intraclass correlation (ICC) coefficient (0.00–0.20 
poor, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 
good and 0.81–1.00 excellent correlation). ADCs 
were averaged between the two observers for fur-
ther analysis. ADCmin Receiver-operating char-
acteristic (ROC) curve analysis was conducted for 
GITH, ITSS, enhancement pattern and ADCmin, 
and sensitivity , specificity, positive predictive 
value (PPV) and negative predictive value (NPV) 
were calculated for differentiating PCNSL from 
GBM.21 Areas under the curve (AUCs) were sta-
tistically compared using a method by Delong et 
al.22 To analyze whether ADCmin were affected by 
microhemorrhage, ADCmin values of the groups 
defined by ITSS were compared using ANOVA in 
both GBM and PCNSL patients. A value of P < 0.05 
Brought to you by | Kyoto University
Authenticated
Download Date | 6/17/15 7:44 AM
Radiol Oncol 2015; 49(2): 128-134.
Sakata A et al. / Absence of intratumoral hemorrhage on MRI in primary CNS lymphoma132
patients (10.3%). When ITSS grade 1 was used as 
the criterion of PCNSL, sensitivity, specificity, PPV, 
and NPV was 47.4%, 89.7%, 69.2%, and 77.8% re-
spectively, whereas ITSS grade 1 or 2 was diagnos-
tic of PCNSL with 78.9% , 66.7% , 53.6% and 86.7%. 
The AUC values were 0.686 and 0.728, respectively 
(p values were 0.0036 and 0.0002, Figure 3). There 
was not statistically significant difference between 
the two curves.
Enhancement patterns of GBM and PCNSL were 
summarized in Table 3: one patient with no con-
trast-enhancement was excluded from this analy-
sis. Most GBMs showed necrotic pattern, while 
most PCNSL showed non-necrotic enhancement. 
Sensitivity, specificity PPV and NPV were 83.3%, 
94.9%, 88.2% and 92.5%, respectively.
ADCmin was significantly lower for lymphoma 
than for GBM (0.487 ± 0.09 × 10-3 mm2/s and 0.645 
± 0.15 × 10-3 mm2/s, respectively; p = 0.001 with stu-
dent t-test). ROC curve analysis of ADCmin found 
the optimal cutoff value to be 0.629 mm2/s (sensi-
tivity: 100%, specificity: 53.8%, PPV: 51.4%. and 
NPV: 100%). There was not statistically significant 
differences between AUCs of ITSS and ADCmin (p 
value = 0.68) (Figure 4).
Discussion
Our results demonstrated that ITSS on SWI can aid 
to differentiate PCNSL from GBM compared with 
GITH on T2WI. However, in this study cohort, 
more than half of PCNSL patients showed positive 
ITSS (i.e., ≥ 2), including 4 patients with ITSS grade 
3. The frequency of positive ITSS in PCNSL was 
much higher than in previous reports, resulting in 
the lower specificity of 66.7%.
Conventional imaging technique, especially 
CE-T1WI, is useful for differentiating PCNSL and 
GBM. Most GBMs show heterogeneous enhance-
ment with variable size of necrotic foci, while 
PCNSL typically shows homogenous enhancement 
because of paucity of intratumoral necrosis, espe-
cially in immunocompetent patients. However, up 
to 10% of patients show atypical enhancement pat-
terns in GBM and PCNSL.1,19 Therefore, further im-
aging technique is warranted for more appropriate 
evaluation.
Hemorrhagic and necrotic foci are commonly 
observed in GBM.23 Previous studies have also 
showed that ITSS on T2*-weighted imaging or SWI 
is more frequently detected in high-grade glio-
ma.24,25 Conversely, in immunocompetent PCNSL 
patients, intratumoral hemorrhage before therapy 
has rarely been observed. On CT and conventional 
MRI, tumor-associated hemorrhage was reported 
in 0‒8% of PCNSL cases.1,6,8,10 Based on this rarity, 
the presence of hemorrhage or calcification is used 
to exclude PCNSL from the differential diagnosis.
Previous reports on SWI have confirmed non-
SWI results.13-15,21,26 Kim et al., first demonstrated 
the presence of ITSS, particularly grade 3, could 
distinguish high-grade glioma from PCNSL with 
100% specificity, although their study included 
only 7 patients with PCNSL.13 Radbruch et al., also 
recently reported that ITSS was not observed in 
any of 14 patients with B-cell PCNSL, with the ex-
ception of 1 case of T-cell lymphoma.14 Peters et al., 
also showed that SWI is useful for differentiating 
PCNSL from GBM, although 1 in 4 patients with 
PCNSL showed grade 2 ITSS.15 Previous studies 
have suggested nearly complete absence of ITSS in 
PCNSL.13-15,21,26
However, on pathological examination, necro-
sis and hemorrhage are occasionally observed in 
PCNSL.27 Some case reports have described PCNSL 
presenting with intracerebral hemorrhage in both 
immunocompetent and immunocompromised pa-
tients.16-18 In a study of 10 immunocompetent PCNSL 
patients, small hemorrhage was found on MRI in 4 
of 19 lesions (21%).9 Moreover, Kickingereder et al., 
have recently reported presence of the ITSS in 6 out 
of 19 PCNSL patients on 3T MRI.19 These findings 
are comparable to our result. SWI is much more sen-
sitive to susceptibility difference than conventional 
FIGURE 4. Receiver-operating charac-
teristic curve analysis of minimum ap-
parent diffusion coefficient (ADCmin) 
and intratumoral susceptibility signal 
(ITSS) grading to differentiate prima-
ry central nervous system lymphoma 
from glioblastoma multiforme. ADCmin 
≤ 0.629 mm2/s is diagnostic of primary 
central nervous system lymphoma with 
100% sensitivity and 53.8% specificity.
FIGURE 3. Receiver-operating charac-
teristic curve analysis of intratumoral 
susceptibility signal (ITSS) grading to 
differentiate primary central nervous 
system lymphoma from glioblastoma 
multiforme. ITSS grades≤ 2 is diagnostic 
of primary central nervous system lym-
phoma with 78.9% sensitivity and 66.7% 
specificity, not as high as in previous 
studies.
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MRI, including T2*-weighted imaging24,28,29, and 
is considered to identify more small hemorrhagic 
lesions within the tumors. Actually, in the present 
study, patients with positive ITSS were twice as 
common as those with GITH in both groups. This is 
in accordance with the recent report by Ding et al., 
demonstrating the significant difference in the de-
tecting rate of intra-tumoral hemorrhage in patients 
with GBM and brain metastasis between the con-
ventional MR imaging and SWI.21 Therefore, con-
ventional MR including T2*WI seems insensitive to 
hemorrhagic change, and unsuitable for differenti-
ating GBM from PCNSL based on the absence of 
intratumoral hemorrhage.
This study showed much higher frequency of 
positive ITSS in PCNSL patients compared with 
previous studies. Several factors may contribute to 
this result. One possible explanation is that SWI in 
this study used thinner slices than previous studies. 
Nandigum et al., demonstrated that SWI acquired 
with thinner slices in a higher magnetic field de-
tected significantly more cerebral microbleeds.30 
Previous SWI studies on PCNSL have reported 
almost no ITSS13,14, but used 2.5- or 3-mm slice 
thicknesses, thicker than used in this study (i.e., 
1.2 or 2 mm). Peters et al., used 1-mm slice thick-
ness and found grade 2 ITSS in 1 of 4 patients with 
PCNSL (diffuse large B-cell lymphoma).15 Thinner 
slice thickness thus appears more sensitive to small 
foci of hemorrhage and may have contributed to 
higher ITSS grades in our PCNSL cases compared 
to previous reports. The other technical factor is the 
difference in head coils used in studies. Previous 
studies used 8- to 12-channel head coils13-15, where-
as the present study used a 32-channel brain coil, 
which improves the signal-to-noise ratio (SNR).31 
SWI was acquired at high resolution, but there is a 
trade-off between resolution and SNR. With lower 
SNR, lesion detectability is impaired32,33, which 
may also have contributed to the differences with 
previous studies. 
Several authors investigate the role of other 
advanced techniques, especially DWI, in evalu-
ation of differentiation of PCNSL and GBM.12,34,35 
Generally, the ADC values of PCNSL are low, re-
flecting the high degree of cellularity. However, 
according to several earlier investigations, the dif-
ferences in ADC between patients with PCNSL and 
those with glioblastoma were not always statisti-
cally significant.35 Our results showed there were 
significant differences between both groups, but its 
specificity was relatively low, which is consistent 
with previous studies. We also tested if the pres-
ence of ITSS effects ADC values, but the ADC val-
ue of the tumor did not differ depending on the 
amount of microhemorrhage.
Our results showed the diagnostic capability of 
ITSS for differentiating PCNSL from GBM were 
comparable to that of ADCmin, however, as a sin-
gle parameter, both of them were not so specific 
as previously described.13-15,21,26 Kickingereder et al., 
showed that ITSS as an additional imaging param-
eter allowed correct classification of the atypical 
GBM (i.e. GBM showing homogenous enhance-
ment) and PCNSL.19 Therefore, considering with 
the limited diagnostic capability of ITSS, combined 
analysis of several parameters obtained by other 
imaging technique, such as PWI12, ASL26 and MRS19 
should be considered in the clinical practice.
Some limitations in this study must be con-
sidered. The sample size was relatively small. 
However, the case number is more than or com-
parable to former studies. Another limitation was 
that we included patients who were treated with 
steroids before imaging. Steroid therapy is well 
known to disrupt cellular morphology, which 
may affect imaging appearance.5,36 However, 
no patients with steroid administration prior to 
MRI showed positive ITSS, and steroid use had 
minimal effect on our results. We also included 
one human T-lymphotropic virus type 1-positive 
case that may potentially have arisen in an im-
munocompromised patient. PCNSL in an immu-
nocompromised host with primary CNS T-cell 
lymphoma is known to have a relatively high in-
cidence of intratumoral hemorrhage11,37, but the 
patient in this study showed no GITH or ITSS. 
Finally, Epstein-Barr virus infection is another 
important factor that must be considered. Lee et 
al., recently demonstrated that Epstein-Barr virus 
-positive PCNSL cases showed intratumoral ne-
crosis or hemorrhage more frequently than cases 
with Epstein-Barr virus -negative PCNSL, even in 
the absence of HIV infection.38 No description of 
Epstein-Barr virus infection status has been avail-
able in previous studies on ITSS13-15, and this was 
also the case for this study. PCNSL with GITH or 
ITSS could potentially be related to Epstein-Barr 
virus infection, but no conclusion can be drawn 
within this study.
In conclusion, low ITSS grades can differenti-
ate PCNSL from GBM. However, specificity in this 
study was relatively low, and PCNSL cannot be 
excluded based solely on the presence of an ITSS. 
Careful evaluation using several imaging tech-
nique is important.
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